Research Study (1)
< Back to Research Studies

4RTNI-2: Four Repeat Tauopathy Neuroimaging Initiative (Cycle 2)

Condition Studied
Primary Progressive Aphasia (PPA)
Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
Primary Tau
Corticobasal Degeneration (CBD)
Progressive Supranuclear Palsy (PSP)
Status
Closed
Principal Investigator
Sponsor
National Institutes of Health (NIH)
Contact Coordinator

Dr. Boxer leads this initiative that involves eight sites across North America. 4RTNI evaluates participants with primary tauopathies, including PSP, CBS, and variant tauopathy syndromes.  Additionally, 4RTNI enrolls healthy individuals.  The study will provide information about the relative value of novel imaging techniques for diagnosis, as well as the value of imaging techniques versus testing of blood and cerebrospinal fluid (CSF) ‟biomarkers.”

 

For questions, please contact: [email protected]